Martin And Harris Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 31-01-2024
- Paid Up Capital ₹ 0.21 M
as on 31-01-2024
- Company Age 44 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 1090.75%
(FY 2020)
- Profit 883.95%
(FY 2020)
- Ebitda -89.69%
(FY 2020)
- Net Worth 2.96%
(FY 2020)
- Total Assets 6.29%
(FY 2020)
About Martin And Harris Pharmaceuticals
- CIN/LLPIN
U70100PB1980PTC051015
- Company No.
022803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jul 1980
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Martin And Harris Pharmaceuticals?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sushma Berlia | Director | 10-Nov-2006 | Current |
Kalpana Umakanth | Director | 05-Jan-2016 | Current |
Padmakar Sawant | Director | 31-Mar-2001 | Current |
Financial Performance of Martin And Harris Pharmaceuticals.
Martin And Harris Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1090.75% increase. The company also saw a substantial improvement in profitability, with a 883.95% increase in profit. The company's net worth moved up by a moderate rise of 2.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Martin And Harris Pharmaceuticals?
In 2018, Martin And Harris Pharmaceuticals had a promoter holding of 67.15% and a public holding of 32.85%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Walter Bushnell Lifescience Private LimitedActive 2 years 9 months
Kalpana Umakanth is a mutual person
- Walter Bushnell Research And Development Center Private LimitedActive 1 year 9 months
Kalpana Umakanth is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Martin And Harris Pharmaceuticals?
Unlock and access historical data on people associated with Martin And Harris Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Martin And Harris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Martin And Harris Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.